Safety of Eluryng in a 38-Year-Old Female with No Other Contraindications

Eluryng is safe to use in a 38-year-old female with no contraindications, though caution should be exercised due to age-related risk factors.

Risk Assessment for Hormonal Contraceptives at Age 38

Age 38 alone is not a contraindication for combined hormonal contraceptives like Eluryng, but it represents a point where risk assessment becomes increasingly important 1
Women over 35 years who smoke should not use combined hormonal contraceptives due to significantly increased cardiovascular risk 2
For non-smoking women with no other risk factors, combined hormonal contraceptives remain a viable option through perimenopause 1

Eluryng should not be used in women with a history of deep vein thrombosis, pulmonary embolism, stroke, transient ischemic attack, or during prolonged immobilization 1
Other contraindications include pregnancy, history of breast cancer, undiagnosed vaginal bleeding, and certain cardiovascular conditions 1
Combined hormonal contraceptives are contraindicated in women over 35 who smoke due to significantly increased risk of arterial thromboembolism 2

When used correctly, vaginal ring contraceptives have a failure rate of approximately 2% with perfect use and 18% with typical use 1
For maximum effectiveness, the ring should be inserted and removed according to the prescribed schedule, with consistent timing 1
If the patient has no contraindications, Eluryng can provide effective contraception with the convenience of monthly insertion 1

Baseline monitoring should include blood pressure measurement and assessment for any symptoms of thromboembolic disorders 1
Ongoing monitoring should include watching for signs of depression, thromboembolic symptoms, and changes in blood pressure 1
The patient should be advised to report any unusual symptoms promptly, particularly those related to potential cardiovascular events 2

At age 38, the risk-benefit profile begins to shift, requiring more careful consideration of cardiovascular risk factors 2
Non-hormonal contraceptive methods may be considered as alternatives if there are any concerns about hormonal methods 1
For women approaching perimenopause, hormonal contraceptives can help manage irregular cycles while providing contraception 1

Failing to thoroughly assess cardiovascular risk factors in women over 35 using combined hormonal contraceptives 2
Not considering the increased risk of venous thromboembolism with age, even in the absence of other risk factors 1
Overlooking potential drug interactions that may reduce contraceptive effectiveness 1